“Exosome Market Dynamics, Part 1” produced by Select Biosciences was published on June 22, 2015 by Genetic Engineering &Technology News (GEN). Authored by Enal Razvi, Ph.D., and Gary Oosta, Ph.D., this report represents the first of three reports on the exosome marketplace that GEN plans on publishing. This first report is the Select Biosciences industry analysis on exosomes, focusing on the technology trends and evolution of this field. The report describes the penetrance of different technologies into the exosomes space and frame this into the overall evolution of this field—indeed, the utilization of different technology platforms foretells the expansion of specific segments—e.g., RNA cargo analysis vs protein cargo analysis derived from exosomes. In GEN’s belief, these data frame the big picture of the exosomes field. In the next report on this topic, GEN will be exploring the specific biomarkers that have been studied in exosomes/extracellular vesicles thus far. The entire report can be accessed at the link provided below. With regard to the authors, Enal Razvi, Ph.D., conducted his doctoral work on viral immunology and, subsequent to receiving his Ph.D., went on to the Rockefeller University in New York to serve as Aaron Diamond Post-Doctoral fellow under Professor Ralph Steinman (Nobel Prize Winner in 2011 for his discovery of dendritic cells in the early-70s with Dr. Zanvil Cohn). Subsequently, Dr. Razvi completed his research fellowship at Harvard Medical School. For the last two decades Dr. Razvi has worked with small and large companies and consulted for more than 100 clients worldwide. He currently serves as Biotechnology Analyst and Managing Director of SelectBio U.S. He can be reached at email@example.com. Gary M. Oosta holds a Ph.D. in Biophysics from Massachusetts Institute of Technology and a B.A.
Login Or Register To Read Full Story